{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "Established Pharmacologic Class [EPC]|Apolipoprotein B-100 Synthesis Inhibitor [EPC]" in comments (approximate match)
Showing 1 - 1 of 1 results
Status:
US Previously Marketed
Source:
KYNAMRO by KASTLE THERAPS LLC
(2013)
Source URL:
First approved in 2013
Source:
KYNAMRO by KASTLE THERAPS LLC
Source URL:
Class:
NUCLEIC ACID